Total Payments
$1,157
2024 Payments
$261.14
Companies
11
Transactions
40
Medicare Patients
13,026
Medicare Billing
$9.2M
Payment Breakdown by Category
Food & Beverage$1,148 (99.2%)
Education$8.69 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,148 | 39 | 99.2% |
| Education | $8.69 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $444.53 | 9 | $0 (2024) |
| Genentech USA, Inc. | $250.12 | 9 | $0 (2024) |
| ABBVIE INC. | $117.26 | 7 | $0 (2024) |
| Shire North American Group Inc | $101.39 | 3 | $0 (2017) |
| Alimera Sciences, Inc. | $63.24 | 3 | $0 (2023) |
| Allergan Inc. | $52.33 | 3 | $0 (2017) |
| EyePoint Pharmaceuticals US, Inc. | $40.24 | 2 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $25.55 | 1 | $0 (2017) |
| Carl Zeiss Meditec USA, Inc. | $25.47 | 1 | $0 (2024) |
| Harrow Eye, LLC | $22.09 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $261.14 | 10 | Regeneron Healthcare Solutions, Inc. ($122.12) |
| 2023 | $335.64 | 12 | Regeneron Healthcare Solutions, Inc. ($164.29) |
| 2022 | $232.48 | 8 | Genentech USA, Inc. ($151.20) |
| 2019 | $14.60 | 1 | Novartis Pharmaceuticals Corporation ($14.60) |
| 2017 | $312.96 | 9 | Regeneron Healthcare Solutions, Inc. ($133.69) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Carl Zeiss Meditec USA, Inc. | CIRRUS HD-OCT (Device) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Optical Tomography | ||||||
| 12/03/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/15/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $32.01 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/13/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: EYE CARE | ||||||
| 07/23/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/02/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $34.28 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/13/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: EYE CARE | ||||||
| 03/05/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/07/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $55.83 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/31/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: EYE CARE | ||||||
| 09/26/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/12/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $38.77 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/30/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: EYE CARE | ||||||
| 08/07/2023 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: OPTOMETRY | ||||||
| 06/02/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: EYE CARE | ||||||
| 05/23/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $93.84 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/02/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/25/2023 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $20.56 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/18/2023 | EyePoint Pharmaceuticals US, Inc. | YUTIQ (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Chronic Non-infectious Posterior Segment Uveitis | ||||||
| 04/05/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $31.68 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/01/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: EYE CARE | ||||||
| 01/17/2023 | EyePoint Pharmaceuticals US, Inc. | YUTIQ (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Chronic Non-infectious Posterior Segment Uveitis | ||||||
| 12/20/2022 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $20.78 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/13/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/26/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Immunology and Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 3,317 | 25,384 | $6.1M | $2.4M |
| 2022 | 16 | 3,289 | 11,420 | $5.9M | $2.4M |
| 2021 | 16 | 3,162 | 8,586 | $5.2M | $2.2M |
| 2020 | 15 | 3,258 | 8,865 | $5.6M | $2.3M |
Total Patients
13,026
Total Services
54,255
Medicare Billing
$9.2M
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 251 | 2,204 | $3.2M | $1.5M | 47.1% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 51 | 16,860 | $1.1M | $489,656 | 42.9% |
| 67028 | Injection of drug into eye | Office | 2023 | 286 | 1,237 | $838,488 | $100,123 | 11.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 527 | 1,410 | $195,990 | $81,119 | 41.4% |
| 92134 | Imaging of retina | Office | 2023 | 966 | 2,288 | $331,664 | $58,801 | 17.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 639 | 726 | $146,652 | $53,935 | 36.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 161 | 161 | $54,740 | $16,879 | 30.8% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 111 | 113 | $35,030 | $10,480 | 29.9% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 11 | 11 | $37,708 | $9,085 | 24.1% |
| 92250 | Photography of the retina | Office | 2023 | 167 | 172 | $29,928 | $3,969 | 13.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $10,875 | $3,255 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 56 | $8,288 | $2,992 | 36.1% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 12 | 13 | $16,458 | $2,222 | 13.5% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 72 | 96 | $5,664 | $1,657 | 29.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,640 | $874.32 | 33.1% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 271 | 2,512 | $3.7M | $1.8M | 49.1% |
| J3590 | Unclassified biologics | Office | 2022 | 42 | 123 | $377,775 | $170,159 | 45.0% |
| 67028 | Injection of drug into eye | Office | 2022 | 292 | 1,290 | $866,712 | $108,211 | 12.5% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 22 | 2,640 | $178,860 | $78,781 | 44.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 529 | 1,276 | $177,364 | $73,541 | 41.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 696 | 837 | $169,074 | $67,516 | 39.9% |
| 92134 | Imaging of retina | Office | 2022 | 922 | 2,195 | $317,987 | $58,618 | 18.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 100 | 100 | $43,500 | $14,735 | 33.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 104 | 105 | $32,550 | $9,368 | 28.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $14,892 | $4,694 | 31.5% |
About Dr. Wayne Davis, DO
Dr. Wayne Davis, DO is a Retina Specialist healthcare provider based in Columbia, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2009. The National Provider Identifier (NPI) number assigned to this provider is 1265663017.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wayne Davis, DO has received a total of $1,157 in payments from pharmaceutical and medical device companies, with $261.14 received in 2024. These payments were reported across 40 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,148).
As a Medicare-enrolled provider, Davis has provided services to 13,026 Medicare beneficiaries, totaling 54,255 services with total Medicare billing of $9.2M. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology
- Location Columbia, MO
- Active Since 07/28/2009
- Last Updated 04/10/2017
- Taxonomy Code 207WX0107X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265663017
Products in Payments
- OZURDEX (Drug) $169.59
- EYLEA HD (Biological) $160.89
- EYLEA (Biological) $149.95
- EYLEA AFLIBERCEPT INJECTION (Biological) $133.69
- SUSVIMO (Drug) $103.66
- XIIDRA (Drug) $101.39
- Vabysmo (Drug) $98.92
- ILUVIEN (Drug) $63.24
- VABYSMO (Drug) $47.54
- YUTIQ (Drug) $40.24
- ULTRA (Device) $25.55
- CIRRUS HD-OCT (Device) $25.47
- IHEEZO (Drug) $22.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Retina Specialist Doctors in Columbia
Jerry Blair, M.d., Ph.d, M.D., PH.D
Retina Specialist — Payments: $6,121
Retina Specialist $6,121
Dr. Derek Barker, M.d, M.D
Retina Specialist — Payments: $1,842
Retina Specialist $1,842
Mari Keithahn, M.d, M.D
Retina Specialist — Payments: $371.85
Retina Specialist $371.85
William Crosswell, Md, MD
Retina Specialist — Payments: $254.96
Retina Specialist $254.96